Enhanced synthesis of l - threo -3,4-dihydroxyphenylserine by high-density whole-cell biocatalyst of recombinant l -threonine aldolase from Streptomyces avelmitilis

l-threo-3,4-Dihydroxyphenylserine (DOPS) is a chiral unnatural β-hydroxy amino acid used for the treatment of Parkinson disease. We developed a continuous bioconversion system for DOPS production that uses whole-cell biocatalyst of recombinant Escherichia coli expressing l-threonine aldolase (l-TA) genes cloned from Streptomyces avelmitilis MA-4680. Maximum conversion rates were observed at 2 M glycine, 145 mM 3,4-dihydroxybenzaldehyde, 0.75% Triton-X, 5 g E. coli cells/l, pH 6.5 and 10°C. In the optimized condition, overall productivity was 8 g/l, which represents 40 times the synthesis yield possible with no optimization of conditions.     

Genetic Subdivision of Chemosynthetic Endosymbionts of Solemya velum along the Southern New England Coast

Population-level genetic diversity in the obligate symbiosis between the bivalve Solemya velum and its thioautotrophic bacterial endosymbiont was examined. Distinct populations along the New England coast shared a single mitochondrial genotype but were fixed for unique symbiont genotypes, indicating high levels of symbiont genetic structuring and potential symbiont-host decoupling.Studies of endosymbioses between marine invertebrates and sulfur-oxidizing chemosynthetic bacteria have yielded tremendous insight into the biology of bacterium-eukaryote interactions. Though best described for deep-sea vents and cold seeps, these mutualisms, in which symbiont thioautotrophy supports the nutrition of both partners, are also ubiquitous in coastal sediments (17). Our understanding of these interactions stems largely from studies of symbioses involving protobranch bivalves in the family Solemyidae (16). Though solemyids and other species that form chemosynthetic symbioses occur globally, little is known about how symbionts and hosts are structured genetically across distinct populations. Characterizing these patterns is critical for understanding how symbiosis drives the coevolution of interacting species, as well as how environmental heterogeneity and dispersal affect local adaptation. This study examines the geographic structure of genetic variation in the symbiosis between chemosynthetic bacteria and the Atlantic protobranch Solemya velum.Solemya velum is ideal for studying the evolution of highly coadapted bacterium-eukaryote mutualisms. This small bivalve (∼1.5 to 3 cm) burrows in sulfide-rich coastal sediments, where it obtains most of its nutrition from thioautotrophic bacteria living within specialized gill cells (1, 10). Though observed from Florida to Canada (20), the distribution of S. velum is highly patchy, with seemingly suitable habitat often devoid of individuals (12). Consequently, molecular characterizations of this symbiosis have focused primarily on stable and locally abundant populations near Woods Hole, MA. Direct sequencing of the symbiont 16S rRNA gene from these individuals has revealed a single, unique phylotype clustering within the Gammaproteobacteria (5, 6, 9). DNA from this symbiont has been extracted from S. velum ovarian tissue, raising the hypothesis that symbionts are transmitted vertically from mother to offspring (11) and are therefore tightly coupled to the host''s life cycle and evolutionary history.If symbiont acquisition is strictly vertical in Solemya populations, the genealogies of the symbiont and the cotransmitted host mitochondrion should diverge in parallel (cospeciation) (8, 15, 18). However, lateral acquisition involving either symbiont uptake from the environment or horizontal transfer between co-occurring hosts has not been ruled out for Solemya populations and could decouple symbiont and host genealogies (18). Indeed, 16S phylogenies show that symbionts of diverse Solemya species are polyphyletic, a pattern inconsistent with the putative monophyly of the hosts (based on nonmolecular characters) and suggestive of multiple evolutionary origins (2, 9, 16). However, tests for symbiont-host codiversification below the species level in S. velum are lacking; sequence data from multiple populations will help resolve questions of cospeciation and symbiont transmission in this group.Here, distinct Solemya velum populations were genotyped to examine how symbiont diversity covaries with host diversity and geography. Individual bivalves (n = 12 to 22 per site) were collected from mudflats at four sites along the southern New England coast (Fig. ​(Fig.1A).1A). DNA was extracted from the symbiont-containing gills and used for PCR amplification of fragments of the mitochondrial cytochrome c oxidase subunit I gene (COI) and the symbiont 16S gene and hypervariable internal transcribed spacer (16S-ITS) (Table ​(Table1;1; also see the supplemental material). Unambiguous contigs of 340 nucleotides (nt) for the COI locus and 716 nt for the 16S-ITS locus, including 241 nt of the 16S and 475 nt (∼95%) of the ITS, were generated via bidirectional direct sequencing of amplicons using BigDye chemistry. Symbiont identity was confirmed by blasting the 16S-ITS (Woods Hole [WH] phylotype) against an assembly of the S. velum symbiont genome from the same population (C. Cavanaugh, unpublished data). Blastn returned a single full-length hit with 100% identity across the locus. Genotype networks were then inferred via statistical parsimony in the program TCS (3).Open in a separate windowFIG. 1.(A) Locations of Solemya velum collection sites (stars) along the Atlantic Coast were Naushon Island, Woods Hole, MA (WH; 41.514°N, −70.712°W); Lake Tashmoo, Martha''s Vineyard, MA (MV; 41.465°N, −70.623°W); Judith Pond, RI (RI; 41.380°N, −71.502°W); and Shark River Island, NJ (NJ; 40.186°N, −74.030°W). (B) Parsimony networks of host COI and symbiont 16S-ITS genotypes. Open circle, single-nucleotide substitution in either the host COI (top; 340 nt) or symbiont 16S (241 nt); filled circle, single-nucleotide substitution in the ITS portion (475 nt) of the 16S-ITS sequence fragment (716 nt total); diagonal bar, single-nucleotide indel in the symbiont ITS; gen1 and gen2, genotypes 1 and 2. Values in parentheses show the number of S. velum individuals from which sequences were obtained at each site.

TABLE 1.

Symbiont and host primers used in PCR^a and direct sequencing

Prophylactic and Therapeutic Efficacy of Avian Antibodies Against Influenza Virus H5N1 and H1N1 in Mice

Background

Pandemic influenza poses a serious threat to global health and the world economy. While vaccines are currently under development, passive immunization could offer an alternative strategy to prevent and treat influenza virus infection. Attempts to develop monoclonal antibodies (mAbs) have been made. However, passive immunization based on mAbs may require a cocktail of mAbs with broader specificity in order to provide full protection since mAbs are generally specific for single epitopes. Chicken immunoglobulins (IgY) found in egg yolk have been used mainly for treatment of infectious diseases of the gastrointestinal tract. Because the recent epidemic of highly pathogenic avian influenza virus (HPAIV) strain H5N1 has resulted in serious economic losses to the poultry industry, many countries including Vietnam have introduced mass vaccination of poultry with H5N1 virus vaccines. We reasoned that IgY from consumable eggs available in supermarkets in Vietnam could provide protection against infections with HPAIV H5N1.

Methods and Findings

We found that H5N1-specific IgY that are prepared from eggs available in supermarkets in Vietnam by a rapid and simple water dilution method cross-protect against infections with HPAIV H5N1 and related H5N2 strains in mice. When administered intranasally before or after lethal infection, the IgY prevent the infection or significantly reduce viral replication resulting in complete recovery from the disease, respectively. We further generated H1N1 virus-specific IgY by immunization of hens with inactivated H1N1 A/PR/8/34 as a model virus for the current pandemic H1N1/09 and found that such H1N1-specific IgY protect mice from lethal influenza virus infection.

Conclusions

The findings suggest that readily available H5N1-specific IgY offer an enormous source of valuable biological material to combat a potential H5N1 pandemic. In addition, our study provides a proof-of-concept for the approach using virus-specific IgY as affordable, safe, and effective alternative for the control of influenza outbreaks, including the current H1N1 pandemic.     

A proteomic approach for identifying cellular proteins interacting with erythropoietin in recombinant Chinese hamster ovary cells

Identification of the cellular proteins interacting with incompletely folded and unfolded forms of erythropoietin (EPO) in recombinant CHO (rCHO) cells leads to better insight into the possible genetic manipulation approaches for increasing EPO production. To do so, a pull‐down assay was performed with dual‐tagged (N‐terminal GST‐ and C‐terminal hexahistidine‐tagged) EPO expressed in E. coli as bait proteins and cell lysates of rCHO cells (DG44) as prey proteins. Cellular proteins interacting with dual‐tagged EPO were then resolved by two‐dimensional gel electrophoresis (2DE) and identified by MALDI‐TOF MS/MS. A total of 27 protein spots including glucose‐regulated protein 78 (GRP78) were successfully identified. Western blot analysis of GRP78 confirmed the results of the MS analyses. Taken together, a pull‐down assay followed by a proteomic approach is found to be an efficient means to identify cellular proteins interacting with foreign protein in rCHO cells. © 2009 American Institute of Chemical Engineers Biotechnol. Prog., 2010     

Annexin A1 restores Aβ1‐42‐induced blood–brain barrier disruption through the inhibition of RhoA‐ROCK signaling pathway

The blood–brain barrier (BBB) is composed of brain capillary endothelial cells and has an important role in maintaining homeostasis of the brain separating the blood from the parenchyma of the central nervous system (CNS). It is widely known that disruption of the BBB occurs in various neurodegenerative diseases, including Alzheimer's disease (AD). Annexin A1 (ANXA1), an anti‐inflammatory messenger, is expressed in brain endothelial cells and regulates the BBB integrity. However, its role and mechanism for protecting BBB in AD have not been identified. We found that β‐Amyloid 1‐42 (Aβ42)‐induced BBB disruption was rescued by human recombinant ANXA1 (hrANXA1) in the murine brain endothelial cell line bEnd.3. Also, ANXA1 was decreased in the bEnd.3 cells, the capillaries of 5XFAD mice, and the human serum of patients with AD. To find out the mechanism by which ANXA1 recovers the BBB integrity in AD, the RhoA‐ROCK signaling pathway was examined in both Aβ42‐treated bEnd.3 cells and the capillaries of 5XFAD mice as RhoA was activated in both cases. RhoA inhibitors alleviated Aβ42‐induced BBB disruption and constitutively overexpressed RhoA‐GTP (active form of RhoA) attenuated the protective effect of ANXA1. When pericytes were cocultured with bEnd.3 cells, Aβ42‐induced RhoA activation of bEnd.3 cells was inhibited by the secretion of ANXA1 from pericytes. Taken together, our results suggest that ANXA1 restores Aβ42‐induced BBB disruption through inhibition of RhoA‐ROCK signaling pathway and we propose ANXA1 as a therapeutic reagent, protecting against the breakdown of the BBB in AD.     

Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis

A high-resolution method for the separation and analysis of disaccharides prepared from heparin and heparan sulfate (HS) using heparin lyases is described. Ultra-performance liquid chromatography in a reverse-phase ion-pairing mode efficiently separates eight heparin/HS disaccharides. The disaccharides can then be detected and quantified using electrospray ionization mass spectrometry. This method is particularly useful in the analysis of small amounts of biological samples, including cells, tissues, and biological fluids, because it provides high sensitivity without being subject to interference from proteins, peptides, and other sample impurities.     

The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release

Neurotransmitter release by catecholaminergic cells is negatively regulated by prohormone cleavage products formed from plasmin-mediated proteolysis. Here, we investigated the expression and subcellular localization of Plg-R(KT), a novel plasminogen receptor, and its role in catecholaminergic cell plasminogen activation and regulation of catecholamine release. Prominent staining with anti-Plg-R(KT) mAb was observed in adrenal medullary chromaffin cells in murine and human tissue. In Western blotting, Plg-R(KT) was highly expressed in bovine adrenomedullary chromaffin cells, human pheochromocytoma tissue, PC12 pheochromocytoma cells, and murine hippocampus. Expression of Plg-R(KT) fused in-frame to GFP resulted in targeting of the GFP signal to the cell membrane. Phase partitioning, co-immunoprecipitation with urokinase-type plasminogen activator receptor (uPAR), and FACS analysis with antibody directed against the C terminus of Plg-R(KT) were consistent with Plg-R(KT) being an integral plasma membrane protein on the surface of catecholaminergic cells. Cells stably overexpressing Plg-R(KT) exhibited substantial enhancement of plasminogen activation, and antibody blockade of non-transfected PC12 cells suppressed plasminogen activation. In functional secretion assays, nicotine-evoked [(3)H]norepinephrine release from cells overexpressing Plg-R(KT) was markedly decreased (by 51 ± 2%, p < 0.001) when compared with control transfected cells, and antibody blockade increased [(3)H]norepinephrine release from non-transfected PC12 cells. In summary, Plg-R(KT) is present on the surface of catecholaminergic cells and functions to stimulate plasminogen activation and modulate catecholamine release. Plg-R(KT) thus represents a new mechanism and novel control point for regulating the interface between plasminogen activation and neurosecretory cell function.     

High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice

Blood–brain barrier (BBB) breakdown and mitochondrial dysfunction have been implicated in the pathogenesis of Alzheimer''s disease (AD), a neurodegenerative disease characterized by cognitive deficits and neuronal loss. Besides vitamin C being as one of the important antioxidants, recently, it has also been reported as a modulator of BBB integrity and mitochondria morphology. Plasma levels of vitamin C are decreased in AD patients, which can affect disease progression. However, investigation using animal models on the role of vitamin C in the AD pathogenesis has been hampered because rodents produce with no dependence on external supply. Therefore, to identify the pathogenic importance of vitamin C in an AD mouse model, we cross-bred 5 familial Alzheimer''s disease mutation (5XFAD) mice (AD mouse model) with ι-gulono-γ-lactone oxidase (Gulo) knockout (KO) mice, which are unable to synthesize their own vitamin C, and produced Gulo KO mice with 5XFAD mice background (KO-Tg). These mice were maintained on either low (0.66 g/l) or high (3.3 g/l) supplementation of vitamin C. We found that the higher supplementation of vitamin C had reduced amyloid plaque burden in the cortex and hippocampus in KO-Tg mice, resulting in amelioration of BBB disruption and mitochondrial alteration. These results suggest that intake of a larger amount of vitamin C could be protective against AD-like pathologies.